One consideration in using ABT263 is its mechanism of action, which involves the inhibition of antiapoptotic proteins like Bcl‐xL and Bcl‐2, known to induce platelet apoptosis and lead to thrombocytopenia.47 Here, BCL2 is linked to Thrombocytopenia.